ATHLATES: accurate typing of human leukocyte antigen through exome sequencing.
about
Autoimmune diseases - connecting risk alleles with molecular traits of the immune system.The impact of next-generation sequencing technologies on HLA researchImmune DNA signature of T-cell infiltration in breast tumor exomes.OptiType: precision HLA typing from next-generation sequencing data.Evaluation of computational programs to predict HLA genotypes from genomic sequencing data.Typing and copy number determination for HLA-DRB3, -DRB4 and -DRB5 from next-generation sequencing data.HLAscan: genotyping of the HLA region using next-generation sequencing data.Inference of high resolution HLA types using genome-wide RNA or DNA sequencing readsCervical Cancer Neoantigen Landscape and Immune Activity is Associated with Human Papillomavirus Master Regulators.Development and validation of a sample sparing strategy for HLA typing utilizing next generation sequencing.FRED 2: an immunoinformatics framework for Python.Immunoinformatics and epitope prediction in the age of genomic medicine.HLA-HD: An accurate HLA typing algorithm for next-generation sequencing data.pVAC-Seq: A genome-guided in silico approach to identifying tumor neoantigens.Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma.Maternal T-Cell Engraftment Interferes With Human Leukocyte Antigen Typing in Severe Combined ImmunodeficiencyDensity of immunogenic antigens does not explain the presence or absence of the T-cell-inflamed tumor microenvironment in melanoma.Tumor antigen discovery through translation of the cancer genome.Fast and accurate HLA typing from short-read next-generation sequence data with xHLA.Extended exome sequencing identifies BACH2 as a novel major risk locus for Addison's disease.Cancer Immunogenomics: Computational Neoantigen Identification and Vaccine Design.Computational genomics tools for dissecting tumour-immune cell interactions.Principles and Recommendations for Standardizing the Use of the Next-Generation Sequencing Variant File in Clinical Settings.Mutational landscape of MCPyV-positive and MCPyV-negative Merkel cell carcinomas with implications for immunotherapy.Exploiting the neoantigen landscape for immunotherapy of pancreatic ductal adenocarcinoma.4-1BB-Enhanced Expansion of CD8+ TIL from Triple-Negative Breast Cancer Unveils Mutation-Specific CD8+ T Cells.Informatics for cancer immunotherapy.Accuracy of Programs for the Determination of Human Leukocyte Antigen Alleles from Next-Generation Sequencing Data.Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance.Exceptional response to pembrolizumab in a metastatic, chemotherapy/radiation resistant ovarian cancer patient harboring a CD274/PD-L1-genetic rearrangement.Concepts Collide: Genomic, Immune, and Microbial Influences on the Tumor Microenvironment and Response to Cancer Therapy.ALPHLARD: a Bayesian method for analyzing HLA genes from whole genome sequence dataA dormant TIL phenotype defines non-small cell lung carcinomas sensitive to immune checkpoint blockers
P2860
Q26767040-B858F405-1A0F-480A-AC04-4C63164CB4BDQ26796663-A441ABD2-2D17-4A5F-9A7D-5A866C185FD1Q30377226-CF8728AB-A037-41CD-80CB-4F36687E8A7EQ30843963-D310A53C-7109-41DD-9022-AA3091A189CCQ31140417-F2E4B457-D997-4292-87A8-193CC8C2A3E5Q31158604-886590A0-17AA-418B-8F3E-D40869C4AEB8Q33667885-B249B4BE-820F-467E-B6D7-4F568B05E89EQ33669140-63CB08DC-5AE7-41F6-BCE9-7EFB6EB9822FQ33806351-D5A7070D-27D3-40E1-A5D2-A4E5D3A0BE5DQ35647298-9DF70E7E-DCA9-42FA-B7A8-D5E34601B4D7Q36011145-CB34166E-630A-44CC-9DDF-D3E3F5BCF8D7Q36304147-D9815861-87DC-42DF-8AE7-51F0946DD56BQ36350030-16677FAD-23A0-47AA-9191-837CFDADFBA7Q36521595-22004704-DFFC-4DEA-B8D4-9D21DD916226Q36730827-CE6CFBC6-1B37-465F-9A4D-4AA6DDDA875CQ36990709-8710A7BA-B920-43C5-AE21-8B5485F0EE64Q37473978-98324179-74EA-49D5-A69D-C7DD898E8F30Q38203472-2DA31F95-CA73-4624-859B-937283323ABCQ38695366-FF465E68-F492-4C43-9490-F1B0B531C053Q38799740-05F7DD5A-BF46-463C-AEC7-D8E3E5E305CCQ38847147-1FA901DE-4B3F-43F6-8639-35FA7294C7FAQ38885361-3E657BC1-772B-47BB-A904-D509438DC041Q38896358-50C6DF11-ACC7-4E0B-9B5D-E8A244D425BEQ39926027-06CC509D-10B1-486D-9DA2-B9611FAF5A3FQ41514095-6C7892E0-99D5-489F-9DF8-872773D820C9Q46863819-0EF9B412-8620-4C08-848B-E4905DF109B9Q47290509-DB1D7E40-FE4D-4075-A801-D5B19DEF0353Q47564718-EBEF2371-ADE6-447D-8DC4-A4083485F198Q48173597-56DF5BE0-FCBE-4281-BF92-B63AB2714594Q49913387-EBDB62C3-0AF4-4ACD-8EDE-E6AC855D4673Q55034685-E3CEF8E7-BAA8-4B57-A31D-75A7C7B7E1CAQ58544658-9307BF37-503F-4998-8E87-8045079AB5BEQ58790788-5FBC9F32-04A3-4A30-9F7B-BFFB3D8223E2
P2860
ATHLATES: accurate typing of human leukocyte antigen through exome sequencing.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
ATHLATES: accurate typing of human leukocyte antigen through exome sequencing.
@en
ATHLATES: accurate typing of human leukocyte antigen through exome sequencing.
@nl
type
label
ATHLATES: accurate typing of human leukocyte antigen through exome sequencing.
@en
ATHLATES: accurate typing of human leukocyte antigen through exome sequencing.
@nl
prefLabel
ATHLATES: accurate typing of human leukocyte antigen through exome sequencing.
@en
ATHLATES: accurate typing of human leukocyte antigen through exome sequencing.
@nl
P2093
P2860
P356
P1476
ATHLATES: accurate typing of human leukocyte antigen through exome sequencing.
@en
P2093
Brian Duffy
John D Pfeifer
Robi D Mitra
Thalachallour Mohanakumar
P2860
P356
10.1093/NAR/GKT481
P407
P577
2013-06-08T00:00:00Z